Agenda
Vivos Therapeutics Inc. (NASDAQ: VVOS) is a medical technology company focused on developing and commercializing innovative treatments for adult patients suffering from sleep-disordered breathing.
Keynote speaker: Kirk Huntsman, CEO
Revive Therapeutics, (OTC Pink: RVVTF) (CSE: RVV) is a life sciences company focused on the research and development of therapeutics for infectious diseases and rare disorders, and it is prioritizing drug development efforts to take advantage of several regulatory incentives awarded by the FDA.
Keynote speaker: Michael Frank, President & CEO
Lobe Sciences (OTC Pink: GTSIF) (CSE: LOBE) is engaged in drug research and development using psychedelic compounds and the development of innovative devices and delivery mechanisms to improve mental health and wellness.
Keynote speaker: Phillip Young, CEO
AMMO, Inc. (NASDAQ: POWW) designs and manufactures products for a variety of aptitudes, including law enforcement, military, sport shooting and self-defense.
Keynote speaker: Chris Larson, Founder
Foothills Exploration, Inc. (OTC: FTXP) is an oil and gas exploration company focused on natural gas exploration and participating in the global energy transition.
Keynote speaker: Chris Jarvis, Executive VP
Xtreme Fighting Championships, Inc. (OTC Pink: DKMR), now partnered with the FOX family of networks, is the first publicly traded premier international mixed martial arts organization with offices throughout the United States and South America.
Keynote speaker: Steve Smith, President & CEO
Ur-Energy (NYSE American: URG) (TSX: URE) is a uranium mining company operating the Lost Creek in-situ recovery uranium facility in south-central Wyoming and has produced, packaged and shipped more than 2.6 million pounds since commencement.
Keynote speaker: Jeffrey Klenda, Chairman & CEO
International Consolidated Companies, Inc. (OTC Pink: INCC) is focused on acquiring and expanding businesses that offer services and technologies to assist medical marijuana growers and patients.
Keynote speaker: Antonio Uccello, CEO
PHI Group, Inc. (OTC Pink: PHIL) primarily focuses on mergers and acquisitions and invests in select industries and special situations that may substantially enhance shareholder value.
Keynote speaker: Henry Fahman, Chairman & CEO
Enzolytics, Inc. (OTC Pink: ENZC) is a drug development company committed to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases.
Keynote speaker: Charles Cotropia, CEO
First Graphene Ltd. (OTC Pink: FGPHF) (ASX: FGR) is the leading supplier of high-performing, graphene products with a robust manufacturing platform based upon captive supply of high-purity raw materials and an established 100 tonne/year graphene production capacity.
Keynote speaker: Warwick Grigor, Chairman
The Emerging Growth Conference focus and coverage includes a wide range of growth sectors and timely market themes, including, augmented reality, artificial intelligence, scientific, medical instruments and therapeutics, biotechnologies, cannabis, food & beverage, energy and more.
Our conference serves as a vehicle for Emerging Growth to build relationships with our existing and potential clients. Accordingly, a certain number of the presenting companies are our current clients, and some may become our clients in the future. In exchange for services we provide, our clients pay us fees in the form of cash and securities, and we may currently have, or in the future may have investments in the securities of certain of the presenting companies. Finally, certain of the presenting companies have paid us a fee to secure a presentation time slot or to present generally.
The presentations to be delivered by the presenting companies (including any handouts of written materials) have not been approved, endorsed by or otherwise reviewed by EmergingGrowth.com nor should they in any way be construed to have been made in connection with the offer to sell or a solicitation of an offer to buy securities. Please consult an investment professional before investing in anything viewed on the Emerging Growth Conference or on EmergingGrowth.com.
Thank you for your interest in our conference, and we look forward to your participation in future conferences.
